212 related articles for article (PubMed ID: 35122056)
1. LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-κB signaling axis.
Wu G; Xu Y; Schultz RD; Chen H; Xie J; Deng M; Liu X; Gui X; John S; Lu Z; Arase H; Zhang N; An Z; Zhang CC
Nat Cancer; 2021 Nov; 2(11):1170-1184. PubMed ID: 35122056
[TBL] [Abstract][Full Text] [Related]
2. LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.
Mai S; Hodges A; Chen HM; Zhang J; Wang YL; Liu Y; Nakatsu F; Wang X; Fang J; Xu Y; Davidov V; Kang K; Pingali SR; Ganguly S; Suzuki M; Konopleva M; Prinzing B; Zu Y; Gottschalk S; Lu Y; Chen SH; Pan PY
Cancer Res; 2023 Dec; 83(24):4047-4062. PubMed ID: 38098451
[TBL] [Abstract][Full Text] [Related]
3. LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development.
Huang R; Liu X; Kim J; Deng H; Deng M; Gui X; Chen H; Wu G; Xiong W; Xie J; Lewis C; Homsi J; Yang X; Zhang C; He Y; Lou Q; Smith C; John S; Zhang N; An Z; Zhang CC
Cancer Immunol Res; 2024 Mar; 12(3):350-362. PubMed ID: 38113030
[TBL] [Abstract][Full Text] [Related]
4. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma.
Fan J; Li J; Han J; Zhang Y; Gu A; Song F; Duan J; Yin D; Wang L; Yi Y
Mol Immunol; 2021 Aug; 136():82-97. PubMed ID: 34098344
[TBL] [Abstract][Full Text] [Related]
5. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
[TBL] [Abstract][Full Text] [Related]
6. LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation.
Yeboah M; Papagregoriou C; Jones DC; Chan HTC; Hu G; McPartlan JS; Schiött T; Mattson U; Mockridge CI; Tornberg UC; Hambe B; Ljungars A; Mattsson M; Tews I; Glennie MJ; Thirdborough SM; Trowsdale J; Frendeus B; Chen J; Cragg MS; Roghanian A
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32870822
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.
Alvarez SE; Harikumar KB; Hait NC; Allegood J; Strub GM; Kim EY; Maceyka M; Jiang H; Luo C; Kordula T; Milstien S; Spiegel S
Nature; 2010 Jun; 465(7301):1084-8. PubMed ID: 20577214
[TBL] [Abstract][Full Text] [Related]
8. The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-κB activation.
Hadweh P; Habelhah H; Kieff E; Mosialos G; Hatzivassiliou E
Cell Signal; 2014 Dec; 26(12):2730-7. PubMed ID: 25134449
[TBL] [Abstract][Full Text] [Related]
9. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
10. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
11. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.
Varfolomeev E; Goncharov T; Maecker H; Zobel K; Kömüves LG; Deshayes K; Vucic D
Sci Signal; 2012 Mar; 5(216):ra22. PubMed ID: 22434933
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion.
Jang KW; Lee KH; Kim SH; Jin T; Choi EY; Jeon HJ; Kim E; Han YS; Chung JH
J Cell Biochem; 2011 Dec; 112(12):3612-20. PubMed ID: 21793045
[TBL] [Abstract][Full Text] [Related]
13. The Orphan Immune Receptor LILRB3 Modulates Fc Receptor-Mediated Functions of Neutrophils.
Zhao Y; van Woudenbergh E; Zhu J; Heck AJR; van Kessel KPM; de Haas CJC; Aerts PC; van Strijp JAG; McCarthy AJ
J Immunol; 2020 Feb; 204(4):954-966. PubMed ID: 31915259
[TBL] [Abstract][Full Text] [Related]
14. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
[TBL] [Abstract][Full Text] [Related]
16. The E3 ubiquitin ligase TRAF2 can contribute to TNF-α resistance in FLT3-ITD-positive AML cells.
Schnetzke U; Fischer M; Spies-Weisshart B; Zirm E; Hochhaus A; Müller JP; Scholl S
Leuk Res; 2013 Nov; 37(11):1557-64. PubMed ID: 23998902
[TBL] [Abstract][Full Text] [Related]
17. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.
Borghi A; Verstrepen L; Beyaert R
Biochem Pharmacol; 2016 Sep; 116():1-10. PubMed ID: 26993379
[TBL] [Abstract][Full Text] [Related]
18. Siva-1 promotes K-48 polyubiquitination of TRAF2 and inhibits TCR-mediated activation of NF-kappaB.
Gudi R; Barkinge J; Hawkins S; Prabhakar B; Kanteti P
J Environ Pathol Toxicol Oncol; 2009; 28(1):25-38. PubMed ID: 19392652
[TBL] [Abstract][Full Text] [Related]
19. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
[TBL] [Abstract][Full Text] [Related]
20. Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells.
So T; Soroosh P; Eun SY; Altman A; Croft M
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2903-8. PubMed ID: 21282629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
